Timothy M Thomson

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsVirologyNatural products and bioactive compoundsCheminformatics and quantitative structure-activity relationshipsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells.

Míriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada

|Feb 04, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors.

Erika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela

|Jul 01, 2024
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.

Blanca D López-Ayllón, Silvia Marin, Marco Fariñas Fernández

|Jun 19, 2024
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation.

Maria Nuria Peralta-Moreno, Yago Mena, David Ortega-Alarcon

|Apr 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors.

Maria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon

Pageof 2